Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-11Clinical Trial Update: A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study [Phase 2]
This clinical trial update notes that the Phase 2 study of ASP8273 for subjects with non-small cell lung cancer with EGFR activating mutatio…
-
CLINICAL_TRIALS withdrawal · 2017-06-27Clinical Trial Update: Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors [NA]
A clinical trial evaluating immunochemotherapy with optional hypofractionated radiation for complete response in solid tumors has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating MPDL3280A (atezolizumab) plus CDX-1401 in NY-ESO-1 positive non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-05Clinical Trial Update: ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors [Phase 1]
Phase 1 clinical trial of ENB robotic ICG guided surgery for targeting small lung tumors in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-23Clinical Trial Update: Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR) [Phase 2]
A Phase 2 trial (ImmunoSABR) combining SABR and L19-IL2 for stage IV non-small cell lung cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer [NA]
The clinical trial evaluating losartan for pulmonary fibrosis in patients with stage I–III non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-04-14Clinical Trial Update: DE-CT in Lung Cancer Proton Therapy [NA]
A clinical trial titled DE-CT in Lung Cancer Proton Therapy (NCT02844140) sponsored by Maastricht Radiation Oncology has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-13Clinical Trial Update: Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation [NA]
The clinical trial evaluating pulmonary rehabilitation for improved lung function in locally advanced non-small cell lung cancer patients un…
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial of a MUC1-targeted immunotherapy for unresectable stage III non-small cell lung cancer has been withdrawn, with Merck KGaA a…
-
CLINICAL_TRIALS withdrawal · 2017-02-13Clinical Trial Update: Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of ibrutinib followed by ibrutinib in combination with nivolumab in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]
Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating stereotactic body radiation therapy for stage I–II non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-05Clinical Trial Update: Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer [Phase 2, Phase 3]
The Phase IIb/III trial of TG4010 immunotherapy in stage IV non-small cell lung cancer was terminated. No efficacy results are provided in t…
-
CLINICAL_TRIALS withdrawal · 2016-12-30Clinical Trial Update: Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation [Phase 3]
A Phase 3 trial comparing adjuvant erlotinib intercalating with chemotherapy versus adjuvant chemotherapy alone in NSCLC with common EGFR mu…
-
EMA withdrawal · 2016-12-21EMA Application withdrawn: Pemetrexed ditromethamine Hospira (pemetrexed ditromethamine)
The EMA withdrew the application for pemetrexed ditromethamine Hospira, a pemetrexed conjugate, for mesothelioma and non-small cell lung car…
-
CLINICAL_TRIALS withdrawal · 2016-12-16Clinical Trial Update: Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer [NA]
A clinical trial evaluating diffusion-weighted MRI for individualized radiation therapy planning in non-small cell lung cancer has been with…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) [Phase 3]
A Phase 3 trial evaluating docetaxel with or without infliximab for cancer-related weight loss in unresectable non-small cell lung cancer; i…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
-
CLINICAL_TRIALS withdrawal · 2016-11-04Clinical Trial Update: A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease [Phase 1]
A Phase 1 study of RO5083945 in combination with cisplatin and gemcitabine or carboplatin and paclitaxel for squamous non-small cell lung ca…
-
CLINICAL_TRIALS withdrawal · 2016-10-12Clinical Trial Update: Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating pazopanib in combination with paclitaxel for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-20Clinical Trial Update: Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer [NA]
A clinical trial evaluating Amixea, a mixture of amino acids, in lean body mass and muscle strength for patients with unresectable advanced …
-
CLINICAL_TRIALS withdrawal · 2016-08-26Clinical Trial Update: Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of auranofin and sirolimus in advanced solid tumors including recurrent non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
An open-label Phase Ib/II trial of BAY 1000394 (roniciclib) in combination with Docetaxel for second- or third-line advanced non-small cell …
-
CLINICAL_TRIALS withdrawal · 2016-08-01Clinical Trial Update: Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating durvalumab with or without bavituximab in previously treated metastatic non-small cell lung cancer has been withd…